Navigation Links
U of M researchers using salmonella to fight cancer
Date:3/9/2011

MINNEAPOLS / ST. PAUL (March 9, 2011) University of Minnesota researchers are using salmonella the bacteria commonly transmitted through food that sickens thousands of U.S. residents each year to do what was once unthinkable: help people.

U of M Masonic Cancer Center researchers believe salmonella may be a valuable tool in the fight against cancer in organs surrounding the gut such as the liver, spleen, and colon since that's where salmonella naturally infects the body.

Researchers want to "weaponize" salmonella, allowing the bacteria to then attack cancer cells in its natural environment.

Trials in animals have already shown salmonella can successfully controlled tumors in the gut. Human clinical trials are already underway at the U of M and are showing promise.

"Many bacteria and viruses - even harmful ones - can be used to fight disease," said Edward Greeno, M.D., lead researcher on the clinical study and Medical Director of the Masonic Cancer Clinic. "We believe it may even be possible to use bacteria to fight cancer."

Scientists have known for centuries that cancer patients sometimes get better after they've been exposed to an infection. For example, Greeno said, there is a published Austrian report from the 1860's on a patient with a large tumor. The patient was placed in the same room as another sick patient with a bad infection. Soon, the tumor became infected and began to shrink in the original patient and nearly disappeared.

Unfortunately, the infection also killed the patient with the tumor.

So the key for this research initiative, Greeno said, was to find a way to get the tumor fighting abilities of salmonella delivered to the patient - without making the patient sick.

What they came up with:

  • Greeno's Medical School colleague, Dan Saltzman, M.D., Ph.D., genetically modified a batch of salmonella to weaken it and added Interlueken 2, or IL-2. "You could think of IL-2 as a guard dog that sniffs around looking for threats inside the body." he said. When it finds one, it calls in an attack by the immune system.
  • Researchers knew if they could make IL-2 near tumors, it would identify the cancerous cells as a threat and trigger an immune response near the tumor.
  • Salmonella naturally finds its way to a person's gut and associated tissues. Salmonella also naturally likes to grow inside of tumor cells. Hence, if you're looking for ways to treat cancer in the bowels, the nearby lymph nodes or the liver - salmonella is a perfect method to deliver a package of IL-2.

In a nutshell, by using genetically modified salmonella packaged with IL-2, Medical School researchers have created a kind of two-prong attack on cancer the immune response called in by IL-2, and the salmonella itself. The therapy is administered simply mixed with a few ounces of water and imbibed orally.

"This probably won't replace other ways of treating cancer such as chemotherapy and radiation," Greeno said. "But it's a promising area of study and we hope it can be a potent tool in our battle against cancer. It also has potential to be a much cheaper and less toxic alternative to chemotherapy and radiation."


'/>"/>

Contact: Nick Hanson
hans2853@umn.edu
612-624-2449
University of Minnesota
Source:Eurekalert

Related medicine news :

1. University of South Florida researchers find blood-brain barrier damaged by disease
2. Boston researchers create SMArt platform architecture, launch $5,000 health app competition
3. UCLA researchers use nano-Velcro technology to improve capture of circulating cancer cells
4. Aging in place preserves seniors independence, reduces care costs, MU researchers find
5. Elderly see pedestrians half as often as younger drivers, according to Ben-Gurion U. researchers
6. Researchers use human cues to improve computer user-friendliness
7. Researchers find new mechanism behind the formation and maintenance of long-term memories
8. Researchers pinpoint genetic pathways involved in breast cancer
9. Penn researchers find new role for cancer protein p53
10. UCSF researchers uncover hormone pathway to fatty liver disease
11. Researchers pinpoint patients who receive greatest benefit from heart failure treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... CALNOC, ... FACP, FACMPE, FACPE, will keynote their upcoming conference – Empowerment, Value and Collaboration – ... the chairman and CEO of the Virginia Mason Health System in Seattle since 2000. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that ... of CM-AT in children aged 3-8 with Autism, is now enrolling at three new ... children across the United States. , “There are currently no approved drugs that ...
(Date:2/23/2017)... ... ... Thomas Vas-Don suffered from severe injury due to an ... successfully recover. In “ Origin & Insertion Charts for Massage Therapists ” (published by ... massage, anatomy , trigger points and referral pain patterns . , In ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... and lobby of a new healthcare contact center in Georgia, PENETRON Specialty Products ... of the nation’s largest healthcare systems recently invested $51 million to purchase and ...
(Date:2/22/2017)... Raton, FL (PRWEB) , ... February 22, 2017 , ... ... primarily from deer antler velvet, announced its products are coming soon to Amazon.com, the ... Clint and Shelley Thomson as a means to develop an effective natural treatment for ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... February 23, 2017 Persistence ... the global market for intraoperative imaging, excerpts from ... at US$ 513.9 million. According to the report, ... on the grounds of increasing adoption of minimally-invasive ... of diagnostic imaging for neurosurgeries. The world,s leading ...
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Prosthetic Devices Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 9.2% over the next ... industry report analyzes the market estimates and forecasts for all the ...
(Date:2/23/2017)... , Feb. 23, 2017 MabVax ... oncology drug development company, announces that it has ... Administration (FDA) authorizing the initiation a Phase I ... for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is ... MabVax plans to initiate the phase I clinical ...
Breaking Medicine Technology: